دورية أكاديمية
SGLT2 inhibitor empagliflozin alleviates cardiac remodeling and contractile anomalies in a FUNDC1-dependent manner in experimental Parkinson’s disease
العنوان: | SGLT2 inhibitor empagliflozin alleviates cardiac remodeling and contractile anomalies in a FUNDC1-dependent manner in experimental Parkinson’s disease |
---|---|
المؤلفون: | Yu, WeiAff1, Aff2, Wang, Lin, Ren, Wei-ying, Xu, Hai-xiaAff5, Aff6, Aff7, Wu, Ne N.Aff5, Aff6, Yu, Dong-hui, Reiter, Russel J., Zha, Wen-liangAff1, Aff10, IDs41401023011440_cor8, Guo, Qing-dongAff11, IDs41401023011440_cor9, Ren, JunAff1, Aff5, Aff6, IDs41401023011440_cor10 |
المصدر: | Acta Pharmacologica Sinica. 45(1):87-97 |
قاعدة البيانات: | Springer Nature Journals |
تدمد: | 16714083 17457254 |
---|---|
DOI: | 10.1038/s41401-023-01144-0 |